Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 25, 2021

SELL
$53.08 - $69.86 $9.21 Million - $12.1 Million
-173,500 Closed
0 $0
Q3 2020

Oct 16, 2020

SELL
$51.29 - $65.09 $584,706 - $742,026
-11,400 Reduced 6.17%
173,500 $9.22 Million
Q2 2020

Jul 20, 2020

SELL
$34.32 - $62.43 $521,664 - $948,936
-15,200 Reduced 7.6%
184,900 $10.8 Million
Q1 2020

Apr 14, 2020

SELL
$32.64 - $73.63 $2.26 Million - $5.1 Million
-69,200 Reduced 25.7%
200,100 $7.89 Million
Q4 2019

Jan 14, 2020

BUY
$48.0 - $59.55 $10.3 Million - $12.8 Million
215,200 Added 397.78%
269,300 $16 Million
Q3 2019

Oct 07, 2019

SELL
$46.64 - $55.39 $60,632 - $72,007
-1,300 Reduced 2.35%
54,100 $2.88 Million
Q2 2019

Jul 11, 2019

BUY
$40.81 - $52.42 $2.26 Million - $2.9 Million
55,400 New
55,400 $2.83 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Hennessy Advisors Inc Portfolio

Follow Hennessy Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.